refactor(asl): ASL frontend architecture refactoring with left navigation

- feat: Create ASLLayout component with 7-module left navigation - feat: Implement Title Screening Settings page with optimized PICOS layout - feat: Add placeholder pages for Workbench and Results - fix: Fix nested routing structure for React Router v6 - fix: Resolve Spin component warning in MainLayout - fix: Add QueryClientProvider to App.tsx - style: Optimize PICOS form layout (P+I left, C+O+S right) - style: Align Inclusion/Exclusion criteria side-by-side - docs: Add architecture refactoring and routing fix reports Ref: Week 2 Frontend Development Scope: ASL module MVP - Title Abstract Screening
2025-11-18 21:51:51 +08:00
parent e3e7e028e8
commit 3634933ece
213 changed files with 20054 additions and 442 deletions
--- a/backend/scripts/test-results/test-results-2025-11-18T07-48-51-245Z.json
+++ b/backend/scripts/test-results/test-results-2025-11-18T07-48-51-245Z.json
@@ -0,0 +1,150 @@
+{
+  "metrics": {
+    "totalTests": 10,
+    "correctDecisions": 0,
+    "accuracy": 0,
+    "consistencyRate": 0,
+    "jsonValidRate": 1,
+    "avgConfidence": 0,
+    "needReviewRate": 1,
+    "confusionMatrix": {
+      "truePositive": 0,
+      "falsePositive": 0,
+      "trueNegative": 0,
+      "falseNegative": 0,
+      "uncertain": 0
+    }
+  },
+  "results": [
+    {
+      "literatureId": "test-001",
+      "title": "Efficacy and Safety of Empagliflozin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial",
+      "expectedDecision": "include",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 8868
+    },
+    {
+      "literatureId": "test-002",
+      "title": "Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes",
+      "expectedDecision": "include",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 7365
+    },
+    {
+      "literatureId": "test-003",
+      "title": "Systematic Review and Meta-Analysis of SGLT2 Inhibitors in Type 2 Diabetes: A Comprehensive Assessment",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 8163
+    },
+    {
+      "literatureId": "test-004",
+      "title": "Dapagliflozin Improves Cardiac Function in Diabetic Rats: An Experimental Study",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 12106
+    },
+    {
+      "literatureId": "test-005",
+      "title": "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy",
+      "expectedDecision": "include",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 4700
+    },
+    {
+      "literatureId": "test-006",
+      "title": "Real-World Experience with SGLT2 Inhibitors: A Retrospective Cohort Study",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 7922
+    },
+    {
+      "literatureId": "test-007",
+      "title": "Pharmacokinetics and Pharmacodynamics of Empagliflozin in Healthy Volunteers",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 7877
+    },
+    {
+      "literatureId": "test-008",
+      "title": "Comparative Effectiveness of SGLT2 Inhibitors versus DPP-4 Inhibitors in Elderly Patients with Type 2 Diabetes",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 11004
+    },
+    {
+      "literatureId": "test-009",
+      "title": "Severe Diabetic Ketoacidosis Associated with SGLT2 Inhibitor Use: A Case Report",
+      "expectedDecision": "exclude",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 11130
+    },
+    {
+      "literatureId": "test-010",
+      "title": "Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Moderate Renal Impairment",
+      "expectedDecision": "uncertain",
+      "actualDecision": "error",
+      "isCorrect": false,
+      "hasConsensus": false,
+      "needReview": true,
+      "avgConfidence": 0,
+      "deepseekResult": null,
+      "qwenResult": null,
+      "processingTime": 7387
+    }
+  ]
+}